Table D3bNasal cavity and paranasal sinus cancer, participants and treatments

StudyRec#No. PtsSettingTx Group% FemaleMedian Age (rng, yrs)% Stage III/IVPrescribed RT Dose to Primary Tumor (Gy)Median Follow-up (rng, mos)Completed RT (%)
Mixed Settings
IMRT vs 3DCRT
Chen, 20071560681°/preop/postop RT± postRT CTx/CCTxIMRT 3DCRT40 (all)61 (27–92) (all)≥87.4 (all)66–72
50–73
49 (3–151)NR
3DCRT vs 2DRT
Dirix, 200713601271°/preop/postop RT3DCRT 2DR16 (all)58 (27–85) (all)≥93.7 (all)50–80 (all)67 (3–307)100 (all)
Chen, 200715601041°/preop/postop RT± postRT CTx/CCTx3DCRT 2DR40 (all)61 (27–92) (all)≥87.4 (all)50–73
50–74
49 (3–151)NR
IMRT vs 2DRT
Chen, 20071560821°/preop/postop RT± postRT CTx/CCTxIMRT 2DR40 (all)61 (27–92) (all)≥87.4 (all)66–72
50–74
49 (3–151)NR

From: Appendix D, Comparative Studies: Full Evidence/Data Abstraction Tables

Cover of Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer [Internet].
Comparative Effectiveness Reviews, No. 20.
Samson DJ, Ratko TA, Rothenberg BM, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.